SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-24-163529
Filing Date
2024-06-18
Accepted
2024-06-18 17:27:36
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-1 d804510ds1.htm S-1 310696
2 EX-5.1 d804510dex51.htm EX-5.1 10888
3 EX-10.19 d804510dex1019.htm EX-10.19 16559
4 EX-10.20 d804510dex1020.htm EX-10.20 23696
5 EX-23.1 d804510dex231.htm EX-23.1 1970
6 EX-FILING FEES d804510dexfilingfees.htm EX-FILING FEES 16430
7 GRAPHIC g804510g0619015852393.jpg GRAPHIC 3340
8 GRAPHIC g804510g0619020141274.jpg GRAPHIC 3006
9 GRAPHIC g804510g22l15.jpg GRAPHIC 587606
  Complete submission text file 0001193125-24-163529.txt   1195254
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 263407249 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-280317 | Film No.: 241053157
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)